This pilot randomized controlled trial evaluates whether combining lower-body electrical muscle stimulation (EMS) with resistance training is feasible and beneficial for physically inactive postmenopausal women, who experience concurrent declines in muscle strength, body composition, arterial elasticity, and cardiac autonomic balance. Sixteen physically inactive postmenopausal women aged 50-70 years are randomly assigned (1:1) to either (A) supervised resistance training combined with lower-body EMS (applied to 6 muscle groups: lower back, lower abdomen, glutes, quadriceps, hamstrings, and calves) or (B) supervised resistance training alone. Both groups complete twelve 50-minute sessions (consisting of a 10-minute warm-up, 30-minute main exercise, and a 10-minute cool-down) over 6 weeks (twice weekly). Assessments before and after the intervention include body composition, lower-body muscle function, arterial stiffness, and 5-minute heart rate variability. The primary aim is to determine the feasibility of the protocol(recruitment, retention, session attendance, and intervention dose delivery) to inform a future definitive trial. Preliminary estimates of intervention effects on the measured outcomes are reported as secondary aims.
BACKGROUND AND RATIONALE Postmenopausal women often experience physiological declines in muscle function, body composition, and cardiovascular health. While resistance training is an established countermeasure, maximizing its efficiency and adherence remains a challenge. Applying lower-body electrical muscle stimulation (EMS) during resistance training may enhance physiological adaptations and overall training effectiveness. This study aims to evaluate the feasibility of combining lower-body EMS with resistance training in physically inactive postmenopausal women to inform the design of a future definitive trial. STUDY DESIGN This is a pilot randomized controlled trial. Participants will be randomly assigned to either an intervention group receiving combined lower-body EMS and resistance training or a control group receiving resistance training alone. Clinical and physiological outcomes will be assessed before and after the intervention period to evaluate preliminary effects. PRIMARY FEASIBILITY OUTCOMES The primary objective is to evaluate the feasibility of the study protocol. Feasibility will be determined by assessing several key components, including: Recruitment: The ability to recruit the target population within the planned timeframe. Retention: The proportion of participants who complete the study and post-intervention assessments. Adherence: Participant attendance and compliance with the scheduled exercise sessions. Intervention Fidelity: The successful delivery of the exercise intensity and EMS protocol as intended. These components will be evaluated against pre-established progression criteria to determine whether the protocol can proceed to a larger trial or requires modification. STATISTICAL APPROACH Feasibility outcomes will be summarized primarily using descriptive statistics. For secondary physiological and clinical outcomes, appropriate statistical methods will be utilized to estimate the preliminary effects of the intervention, comparing changes between the groups while adjusting for baseline measurements. Effect sizes and confidence intervals will be calculated to provide preliminary evidence and to assist with sample size calculations for future large-scale trials.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
16
Electrical muscle stimulation (85 Hz, 350 μs, cycle 11, duty approx 1:2) applied to 6 muscle groups: lower back (erector spinae), lower abdomen, glutes, quadriceps, hamstrings, and calves.
A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main exercise (8 machine-based lower-body resistance exercises, 3 sets of 8-12 repetitions), and a 10-minute cool-down.
Seoul National University
Seoul, Seoul, South Korea
Composite Feasibility Outcome (Recruitment, Retention, Session Attendance, and Intervention Dose Delivery)
The primary outcome is the feasibility of the study protocol, assessed via recruitment rates, participant retention, session adherence, and targeted intervention delivery. These indicators will be evaluated against pre-defined progression criteria using descriptive statistics to determine whether to proceed with or modify the protocol for a future definitive trial. Unit: Percentage
Time frame: Baseline and Week 6
Skeletal Muscle Mass Index (SMI)
Appendicular skeletal muscle mass divided by height squared. Unit: kg/m².
Time frame: Baseline and Week 6
Total Body Muscle Mass
Total skeletal muscle mass of the whole body. Unit: kg
Time frame: Baseline and Week 6
Total Leg Muscle Mass
Combined left and right leg skeletal muscle mass. Unit: kg
Time frame: Baseline and Week 6
Body Fat Percentage
Body fat mass expressed as a percentage of total body weight. Unit: %
Time frame: Baseline and Week 6
Total Body Fat Mass
Absolute total body fat in kilograms. Unit: kg
Time frame: Baseline and Week 6
Estimated Visceral Fat Area (eVFA)
Estimated visceral fat area at the umbilical level. Unit: cm²
Time frame: Baseline and Week 6
Waist Circumference
Circumference measured at the level of the umbilicus. Unit: cm
Time frame: Baseline and Week 6
Waist-to-Hip Ratio (WHR)
Waist circumference divided by hip circumference. Unit: ratio
Time frame: Baseline and Week 6
Body Mass Index (BMI)
Body weight in kilograms divided by the square of height in meters. Unit: kg/m²
Time frame: Baseline and Week 6
Phase Angle
Whole-body bioimpedance phase angle derived from the arctangent of the reactance-to-resistance ratio. Marker of cellular membrane integrity and overall nutritional/health status. Unit: degrees
Time frame: Baseline and Week 6
Dominant Knee Extensor Peak Torque per Body Weight at 60°/s
Peak concentric knee extensor torque normalized to body weight, measured at 60°/sec angular velocity on the dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Non-dominant Knee Extensor Peak Torque per Body Weight at 60°/s
Peak concentric knee extensor torque normalized to body weight at 60°/sec on the non-dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Dominant Knee Flexor Peak Torque per Body Weight at 60°/s
Peak concentric knee flexor (hamstring) torque normalized to body weight at 60°/sec on the dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Non-dominant Knee Flexor Peak Torque per Body Weight at 60°/s
Peak concentric knee flexor torque normalized to body weight at 60°/sec on the non-dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s
Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the dominant limb. Unit: ratio
Time frame: Baseline and Week 6
Non-dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s
Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the non-dominant limb. Unit: ratio
Time frame: Baseline and Week 6
Dominant Total Work Done by Knee Extensor per Body Weight at 180°/s
Total work performed by knee extensors across the test set, normalized to body weight, at 180°/sec angular velocity on the dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Non-dominant Total Work Done by Knee Extensor per Body Weight at 180°/s
Total work performed by knee extensors normalized to body weight at 180°/sec on the non-dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Dominant Total Work Done by Knee Flexor per Body Weight at 180°/s
Total work performed by knee flexors normalized to body weight at 180°/sec on the dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Non-dominant Total Work Done by Knee Flexor per Body Weight at 180°/s
Total work performed by knee flexors normalized to body weight at 180°/sec on the non-dominant limb. Unit: Nm/kg
Time frame: Baseline and Week 6
Average Brachial-Ankle Pulse Wave Velocity (baPWV)
Mean of left and right brachial-ankle pulse wave velocity; primary indicator of large-artery stiffness. Unit: cm/s
Time frame: Baseline and Week 6
Highest Brachial-Ankle Pulse Wave Velocity (baPWV)
The higher of left and right baPWV values, reflecting the most affected limb. Unit: cm/s
Time frame: Baseline and Week 6
Brachial Systolic Blood Pressure (SBP)
Brachial systolic blood pressure. Unit: mmHg
Time frame: Baseline and Week 6
Brachial Diastolic Blood Pressure (DBP)
Brachial diastolic blood pressure. Unit: mmHg
Time frame: Baseline and Week 6
Pulse Pressure (PP)
Pulse pressure calculated as systolic minus diastolic blood pressure. Unit: mmHg
Time frame: Baseline and Week 6
Mean Arterial Pressure (MAP)
Mean arterial pressure derived from systolic and diastolic blood pressure. Unit: mmHg
Time frame: Baseline and Week 6
Average Ankle-Brachial Index (ABI)
Mean of left and right ankle-brachial systolic blood pressure ratio. Unit: ratio
Time frame: Baseline and Week 6
Augmentation Index (AI)
Augmentation index derived from second-derivative photoplethysmography. Unit: unitless
Time frame: Baseline and Week 6
Root Mean Square of Successive Differences (RMSSD)
Root mean square of successive differences between adjacent normal-to-normal RR intervals. Unit: ms
Time frame: Baseline and Week 6
High-Frequency (HF) Power
Spectral power in the high-frequency band (0.15-0.4 Hz); index of parasympathetic (vagal) activity. Unit: ms²
Time frame: Baseline and Week 6
Standard Deviation of NN Intervals (SDNN)
Standard deviation of all normal-to-normal RR intervals; time-domain index of overall heart rate variability. Unit: ms
Time frame: Baseline and Week 6
Low-Frequency (LF) Power
Spectral power in the low-frequency band (0.04-0.15 Hz). Unit: ms²
Time frame: Baseline and Week 6
LF/HF Ratio
Ratio of low-frequency to high-frequency spectral power. Unit: ratio
Time frame: Baseline and Week 6
High-Frequency Normalized Units (HFnu)
HF power expressed in normalized units = HF / (LF + HF) × 100. Unit: n.u.
Time frame: Baseline and Week 6
Low-Frequency Normalized Units (LFnu)
LF power expressed in normalized units = LF / (LF + HF) × 100. Unit: n.u.
Time frame: Baseline and Week 6
Total Power (TP)
Total spectral power up to 0.4 Hz. Unit: ms²
Time frame: Baseline and Week 6
Very-Low-Frequency (VLF) Power
Spectral power in the very-low-frequency band (≤0.04 Hz). Unit: ms²
Time frame: Baseline and Week 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.